Capital Building in Washington DC

Advocacy & Policy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • CMS Proposes Drug Reimbursement Changes Under Medicare Parts C and D

    The Centers for Medicare & Medicaid Services (CMS) released a proposed rule pertaining to Medicare Part C and Part D—two areas of the Medicare program where reforms are being considered as part of the Administration’s “blueprint to lower drug prices and reduce out-of-pocket costs.”

    Learn More
  • Federal Funding Update: Fiscal Year 2019

    On Friday, December 7, President Trump signed into law a two-week Continuing Resolution (CR) to prevent a partial government shutdown. The CR will provide flat funding for those agencies until December 21, 2018, when Congress will need to take further action to fund them.

    Learn More

Random Quote

"ASCO is leading the move to a new data-driven era of discovery in clinical oncology."
Peter Paul Yu, MD, FACP, FASCO
ASCO President, 2014-15